This inventor holds 2 USPTO granted patents. Top assignees: Bristol-Myers Squibb Compnay, Pfizer Corporation. Active years: 2016-2018.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:


Years Active: 2016-2018
Title: Innovations by Susan Lum in Liquid Formulations
Introduction
Susan Lum is a notable inventor based in Toronto, Canada. She has made significant contributions to the field of pharmaceuticals, particularly in the development of liquid formulations for apixaban. With a total of 2 patents, her work has the potential to enhance the administration of this important medication.
Latest Patents
Susan Lum's latest patents include innovative formulations for apixaban. The first patent focuses on apixaban liquid formulations, providing a method of administering this formulation effectively. The second patent also centers on apixaban solution formulations, again detailing a method for administration. These advancements are crucial for improving patient compliance and therapeutic outcomes.
Career Highlights
Throughout her career, Susan Lum has worked with prominent companies in the pharmaceutical industry. She has been associated with Bristol-Myers Squibb Company and Pfizer Corporation, where she has contributed her expertise in drug formulation and development. Her experience in these leading organizations has helped shape her innovative approaches to medication delivery.
Collaborations
Susan has collaborated with various professionals in her field, including her coworker Sherif Ibrahim Farag Badawy. Their joint efforts have likely contributed to the success of her patented innovations.
Conclusion
Susan Lum's contributions to the field of liquid formulations for apixaban demonstrate her commitment to advancing pharmaceutical science. Her patents and career achievements reflect her significant impact on medication administration methods.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile